Some exciting news from the CODE_n Community! When we read the story at the end of last month it was nothing short of phenomenal. One of our alumni, the HealthTech startup SpinDiag, has just drummed up €1.6 million in seed capital. The team plans to use the funding to roll out its revolutionary point-of-care screening system for antibiotic resistance and conduct initial trials in hospitals. The HealthTech startup has been working on its novel solution since 2016, following a spinoff from the Hahn-Schickard R&D institute. The system could potentially save hundreds of thousands of lives, thanks to a simple screening test that can ascertain in as little as 30 minutes if a patient is carrying drug-resistant bacteria and thus requires treatment in isolation from other patients. Introducing the screening systems to hospital wards could drastically reduce mortalities resulting from germs: Colonization and infections can be detected immediately and positive patients treated in isolation, thus preventing the transmission of drug-resistant bacteria in the long term. We spoke to the team about the seed funding initiative and asked them what tips they would give to startups. Of course, we were also dying to hear about their plans!